Jagsonpal Pharmaceuticals Limited — Dividend/Bonus, 27-04-2026: Dividend

Jagsonpal Pharmaceuticals' Board has approved a final dividend of Rs. 4 per equity share for the financial year ended March 31, 2026. This payout, representing 200% on a face value of Rs. 2, offers direct value to shareholders. The dividend is contingent on approval at the upcoming Annual General Meeting. Additionally, the board considered and approved the financial results for the quarter and year ended March 31, 2026.